MedTrace Logo

Reverse Total Shoulder Arthroplasty in Patients Who Exceeded Their Life-expectancy: a Retrospective Study

NCT04807322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2021-03-19

No results posted yet for this study

Summary

Reverse total shoulder arthroplasty (RTSA) has become an established treatment for cuff arthropathy, severe osteoarthritis and in certain fracture cases. Due to the increasingly aging population, patients who have already exceeded their life-expectancy pose a significant challenge to the shoulder surgeon. Therefore, we wanted to investigate patient demographics, hospital stay length, complication rate functional outcome, patient reported outcome scores and mortality retrospectively for patients, who were older than 83 years at time of implantation of a RTSA.

Conditions

  • Reverse Total Shoulder Arthroplasty

Interventions

PROCEDURE

Reverse Total Shoulder Arthroplasty (RTSA)

Implantation of a Reverse Total Shoulder Arthroplasty

Sponsors & Collaborators

  • Bürgerspital Solothurn

    lead OTHER

Principal Investigators

  • Mai Lan Dao Trong, MD · Bürgerspital Solothurn

Eligibility

Min Age
83 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-24
Primary Completion
2020-08-04
Completion
2020-12-21

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04807322 on ClinicalTrials.gov